2nd Quarter - Report

BOCKORNY GROUP, INC. for ABBOTT LABORATORIES

Firm
Client
Income
$70,000
Expenses
—

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Medicare Part D drug benefit False Claims Act

LobbyistCovered position, as disclosed
DAVID BOCKORNY —
MELISSA SCHULMAN —
PAUL SCOTT SHEARER —
NICOLE VENABLE —

Contacted: SENATE; U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES

Food Industry (safety, labeling, etc.) FOO

Infant Nutrition

LobbyistCovered position, as disclosed
DAVID BOCKORNY —
MELISSA SCHULMAN —
PAUL SCOTT SHEARER —
NICOLE VENABLE —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR)

Trade (domestic/foreign) TRD

Global health and development U.S.- Korea Free Trade Agreement U.S. Negotiations on Trans Pacific Partnership U.S. Trade with Panama and Colombia

LobbyistCovered position, as disclosed
MELISSA SCHULMAN New Leg. Assistant to Rep. Thomas Manton (88)
NICOLE VENABLE —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; U.S. Trade Representative (USTR)

Health Issues HCR

Implementation of the Patient Protection and Affordable Health Care Act

LobbyistCovered position, as disclosed
DAVID BOCKORNY —
MELISSA SCHULMAN —
PAUL SCOTT SHEARER —
NICOLE VENABLE —

Contacted: SENATE; U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.